Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/08/2010US7732420 Combinations of transfection lipids exhibiting increased transfection efficiencies
06/08/2010US7732415 Topical treatment or prevention of ocular infections
06/08/2010US7732411 Methods of therapy with thrombin derived peptides
06/08/2010US7732399 complexes composed of a protein or peptide and a gallic acid ester that allow for sustained delivery of the protein or peptide in vivo upon administration of the complex; gallic acid ester is epigallocatechin gallate; for drug delivery
06/08/2010US7732190 Mixture comprising a first functionalized polymer in a first buffer; a second buffer at approximately physiological osmolality; a second functionalized polymer, a substance having at least one cell-adhesion site combined with the first mixture
06/08/2010US7732015 Low cost equipment, high speed manufacturing; uniform particle size; covering openings of micropores
06/08/2010US7731991 Non-food and non-pharmaceutical use of a selected anhydrous dextrose composition
06/08/2010US7731990 Powdery composition for nasal administration
06/08/2010US7731989 Gastric retained gabapentin dosage form
06/08/2010US7731986 comprises a sclerosant liquid, e.g. polidocanol solution, and a gas e.g. O2 or CO2; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins and other disorders involving venous malformation
06/08/2010US7731983 Method and composition for the treatment of scars
06/08/2010US7731981 surgical injection of dehydrated particles or a gel or suspension into the joint; mixtures may also include radiocontrast materials, analgesics, antibiotics, proteoglycans, growth factors, and other cells to promote healing and proper joint function
06/08/2010US7731968 Topical delivery of vaccines
06/08/2010US7731954 Wound dressings comprising hydrated hydrogels and enzymes
06/08/2010US7731944 Hair cosmetic compositions
06/08/2010US7731790 Composition comprising a liquid absorbed on a support based on precipitated silica
06/08/2010US7731758 Implant for subcutaneous or intradermal injection
06/08/2010CA2602037C Indicator for orally administered compositions
06/08/2010CA2506712C Rapidly-decomposing administrable form for releasing ingredients in the oral cavity or in bodily cavities
06/08/2010CA2447178C Pharmaceutical composition for use in hormone replacement therapy
06/08/2010CA2442281C Intravaginal drug delivery devices for the administration of an antimicrobial agent
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/08/2010CA2386547C Orally disintegrating composition comprising mirtazapine
06/08/2010CA2383233C Surface modified particulate compositions of biologically active substances
06/08/2010CA2379210C Composition for enteral nutrition containing fibre
06/08/2010CA2370019C Transdermal therapeutic system with neutralized acrylic pressure-sensitive adhesives
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/08/2010CA2360590C Solution-based transdermal drug delivery system
06/08/2010CA2283684C Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
06/08/2010CA2199516C Needle-less parenteral introduction device
06/03/2010WO2010062996A2 Ribavirin composition
06/03/2010WO2010062835A1 Antioxidant compositions for soft oral tissue and methods of formulation and use there
06/03/2010WO2010062824A2 Enhanced bioactive formulations of resveratrol
06/03/2010WO2010062688A2 Dosage form for insertion into the mouth
06/03/2010WO2010062678A2 Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
06/03/2010WO2010062628A1 Compositions and methods for treating asthma and other lung disorders
06/03/2010WO2010062570A2 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
06/03/2010WO2010062561A1 Advanced nanomaterials for regulating specific cell functions
06/03/2010WO2010062524A1 Extended release oral acetaminophen/tramadol dosage form
06/03/2010WO2010062523A2 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
06/03/2010WO2010062413A1 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
06/03/2010WO2010062394A2 Implantable ocular drug delivery device and methods
06/03/2010WO2010062322A2 Modulation of the immune response
06/03/2010WO2010062261A1 System and method for preparing a controlled releas preparation
06/03/2010WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases
06/03/2010WO2010062191A1 Improved bolus
06/03/2010WO2010062190A1 Improvements in bolus devices for the delivery of active agents to animals
06/03/2010WO2010062147A2 Crystal form of adefovir dipivoxil, preparation method thereof, and pharmaceutical composition containing the same
06/03/2010WO2010061924A1 Avian influenza vaccine
06/03/2010WO2010061921A1 Method for stabilizing l-ascorbic acid, liquid extraction preparation, solid extract, and semi-fluid extract
06/03/2010WO2010061919A1 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
06/03/2010WO2010061880A1 Vesicle preparation
06/03/2010WO2010061846A1 Orally rapidly disintegrating tablet, and process for producing same
06/03/2010WO2010061386A2 Pharmaceutical composition and system for permeabilizing fetal membranes
06/03/2010WO2010061330A1 Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
06/03/2010WO2010061193A2 Compositions with reduced dimer formation
06/03/2010WO2010061147A1 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
06/03/2010WO2010060989A1 Solution of lipophilic substances, especially medicinal solutions
06/03/2010WO2010060958A1 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine
06/03/2010WO2010060886A2 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient
06/03/2010WO2010060875A1 Novel powdered crystalline medicines for inhalation
06/03/2010WO2010060811A2 Surface active proteins as excipients in solid pharmaceutical formulations
06/03/2010WO2010060798A1 Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
06/03/2010WO2010060667A1 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
06/03/2010WO2010060635A2 Solid pharmaceutical composition comprising at least one stabilizing agent
06/03/2010WO2010060624A2 Dry processing and novel forms of lacosamide
06/03/2010WO2010060621A1 Polyurethane plaster for the transdermal application of active substances, and method for the production thereof
06/03/2010WO2010060564A1 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic
06/03/2010WO2010060529A1 Microparticles comprising a salt of 8-hydroxy-2- [ [ ( ir) -2- (4-methoxyphenyl) -l-methylethyl] aminol ethyll -2 (ih) -quinolin one
06/03/2010WO2010060200A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010WO2010060190A1 Plant extract compositions for affecting sleep
06/03/2010WO2010041017A3 Chewable gelled emulsions
06/03/2010WO2010035226A3 Herbal composition and method for the treatment of viral infection
06/03/2010WO2010030598A3 Pharmaceutical formulations comprising pemetrexed
06/03/2010WO2010027498A3 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions
06/03/2010WO2010023690A3 Prolonged release formulation of amisulpride
06/03/2010WO2010021607A3 Pharmaceutical formulation
06/03/2010WO2010020856A3 Rate modulated delivery of drugs from a composite delivery system
06/03/2010WO2010019266A3 Linaclotide-containing formulations for oral administration
06/03/2010WO2010009056A3 Pain relieving patch
06/03/2010WO2009121935A3 Pharmaceutical composition with bisphosphonate
06/03/2010WO2009087632A3 Emulsified wax compositions and uses thereof
06/03/2010US20100137975 Active-substance-coated medical product, method for its production and its uses
06/03/2010US20100137940 Method for Directed Intranasal Administration of a Composition
06/03/2010US20100137844 Delivery devices for modulating inflammation
06/03/2010US20100137843 Delivery devices for modulating inflammation
06/03/2010US20100137842 Ambulatory Infusion Devices With Improved Delivery Accuracy
06/03/2010US20100137696 Medical device with reservoir-based sensors
06/03/2010US20100137512 Polyethylene glycol/polycation block copolymers
06/03/2010US20100137427 Softgel of NLKJ for treating prostate diseases
06/03/2010US20100137418 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
06/03/2010US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/03/2010US20100137304 Novel crystalline forms of the anti-cancer compound zd1839
06/03/2010US20100137271 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100137232 Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eye
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100136130 Preparation for the Controlled Release of Bioactive Natural Substances
06/03/2010US20100136129 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof
06/03/2010US20100136128 Odor control fragrance additive
06/03/2010US20100136127 Solid preparation comprising alogliptin and metformin hydrochloride